Majority of studies have demonstrated tumor suppressor activity of Id4 which is largely based on the evidence that it is epigenetically silencing in cancers such as leukemia[8], breast[9,10], colorectal[11] mouse and human CLL (chronic lymphocytic leukemia[12]) and gastric cancer[13]. Here, ID4 is linked to B-cell chronic lymphocytic leukemia.